Grown Rogue International (GRUSF) Net Cash Flow Growth (3y) (2016 - 2023)
Grown Rogue International (GRUSF) Net Cash Flow Growth (3y) (2016 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | -28.90% |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | -5.41% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 19.55% |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 95.24% |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | -106.21% |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 4.40% |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 17.73% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Grown Rogue International | 110.47 Mn | 98.93 Mn | 5.37 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2023 | 109.67% |
| Apr 30, 2023 | 2.12% |
| Jan 31, 2023 | 80.05% |
| Jan 31, 2022 | 56.90% |
| Oct 31, 2021 | 7,801.48% |
| Jul 31, 2021 | -12,833.61% |
| Apr 30, 2021 | 85.32% |
| Jan 31, 2021 | 5.26% |
| Aug 31, 2018 | 32.96% |
| May 31, 2018 | 60.68% |
| May 31, 2017 | -74.75% |
| Nov 30, 2016 | -35.23% |
| Aug 31, 2016 | 35.89% |